Antithrombotic therapy for venous thromboembolic disease

Chest

Volumn 114, Issue 5 SUPPL., 1998, Pages 561S-578S

  Hyers, Thomas M ^a   Agnelli, Giancarlo ^a   Hull, Russell D ^a   Weg, John G ^a   Morris, Timothy A ^a   Samama, Michel ^a   Tapson, Victor ^a  

^a Occupational Medicine and Pulmonary Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN DERIVATIVE; DALTEPARIN; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; HEPARINOID; HIRUDIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN; STREPTOKINASE; THROMBIN INHIBITOR; TINZAPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

ANTICOAGULATION; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MECHANISM; EMBOLECTOMY; FIBRINOLYTIC THERAPY; HIGH RISK PATIENT; HUMAN; HYPOALDOSTERONISM; INTERVENTIONAL RADIOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; OSTEOPENIA; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SKIN NECROSIS; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; THROMBOEMBOLISM; VEIN THROMBOSIS; VENA CAVA FILTER;

EID: 0031759604     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.5_Supplement.561S     Document Type: Conference Paper

References (10)

1. Foster CS, Genton E, Henderson M, et al, eds. Epidemiology of venous thrombosis. Milbank Mem Fund Q 1972; 50(suppl):1-283
2. Havig O. Deep vein thrombosis and pulmonary embolism: an autopsy study with multiple regression analysis of possible risk factors. Acta Chir Scand 1977; 479(suppl):1-93
3. Coon WW. Venous thromboembolism: prevalence, risk factors and prevention. Clin Chest Med 1984; 5:391-401
4. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326:1240-1245
5. Cogo A, Bernards E, Prandoni E, et al. Acquired risk factors for deep vein thrombosis in symptomatic patients. Arch Intern Med 1994; 154:164-168
6. Simioni P, Prandoni P, Zanon E, et al. Deep venous thrombosis and lupus anticoagulant: a case-control study. Thromb Haemost 1996; 76:187-189
7. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 1997; 127:895-903
8. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125:1-7
9. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-3703
10. Morris GK, Mitchell JR. Warfarin sodium in the prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur. Lancet 1976; 2:869-872